AUTM

While patent filings were up, research institutes and others surveyed started up fewer companies, won fewer patents, and signed fewer licensing and option agreements than they did before the recession.

The Sloan School of Management study so far suggests that a greater degree of interdisciplinary collaboration within universities may lead to more entrepreneurship and technology transfer — but only to an extent.

Tech Transfer Tidbits

Premium

Unico measures 'knowledge transfer' in new report; TEDCO awards tech-development funding; University of Maryland Biotech Institute under microscope; Virginia passes biosciences eco-dev bill

The first repealed rule required that officials from the Oregon DOJ review any business deal worth more than $100,000 between schools in the Oregon university system schools and private entities; while the second required a DOJ review of any deal between Oregon state schools and those from other state systems.

The study suggests it is "unlikely" that patents protecting biomedical inventions "will ever be licensed" if they have remained unlicensed for more than eight years since their priority patent application was filed.

Eli Lilly, Cornell University, and the Kauffman Foundation's iBridge Network each unveiled web-based initiatives for facilitating tech transfer at last week's Association of University Technology Managers annual meeting.

A majority of US tech-transfer offices said their main goals are to provide a service to faculty entrepreneurs and translate university research into commercial products — but much less so to maximize licensing revenue or provide research support, according to the survey.

The settlement terminates a licensing agreement signed between Rockefeller and Ligand in 1992 related to patents and know-how surrounding peptidyl hormone-mediated gene expression technology discovered primarily by a Rockefeller scientist.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.